NEWS IN BRIEF

BIA Separations adds upstream processing facility

By Ben Hargreaves contact

- Last updated on GMT

(Image: BIA Separations)
(Image: BIA Separations)

Related tags: Chromatography, BIA Separations

BIA Separations has completed work on an additional upstream processing laboratory in Ajdovščina, Slovenia.

The new facility will enable the Slovenian company to better link its upstream and downstream processing capabilities, in order to produce viral vectors, phages, and exosomes.

The company stated that the expansion of its manufacturing network would allow those employing its services “full coordination of critical step”​ in upstream processing.

This extends to include upstream choice of cell line, source and supply of materials, and bioreactor processing parameters.

Aleš Štrancar, CEO of BIA Separations, commented, “we now have the capability to manage the interface between upstream and downstream processes, which is key for complex biologics production.”

Being able to manage the transition between upstream and downstream processing had been the objective when BIA had signed an agreement with Nuvonis​.

The partnership allowed BIA access to Nuvonis’ Vero cell bank, which linked up to the former’s chromatographic products.

At the time, Štrancar referred to better links between upstream and downstream processing as “the last frontier in bioprocess manufacturing” ​and, in its latest release, the company highlighted how the new laboratory will have the ability to improve downstream product purification, formulation and stability profiles.

Related news

Show more

Related products

show more

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Related suppliers

Follow us

Products

View more

Webinars